Neudle.com: multiple sclerosis clinically isolated syndrome

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

adverse drug reaction

akinetic mute

algorithm

alternating rapid movement

amyloid angiopathy, cerebral

amyloid angiopathy, cerebral, inflammatory type

amyloid beta protein

amyloid beta-related angiitis

aneurysm

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiitis, isolated of CNS, benign focal

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, cerebral, false negative

angiography, cerebral, reversible abnormality

antibodies to myelin basic protein

antimyelin antibodies

autoimmune cerebellar ataxia

Barkhof MR criteria for MS

basal ganglia, infarction

basal ganglia, lesion of

brain biopsy, false negative

brain volume

brainstem

brainstem, atrophy

brainstem, infarction of

brainstem, lesion of

bulbar palsy

calcium antagonist

Call-Fleming syndrome

carbamazepine

carbon monoxide poisoning

CAT scan, contrast enhanced, delayed

CAT scan, contrast enhanced, double dose

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, serial

central nervous system, infection of

central pontine myelinolysis

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellum

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral edema

cerebral edema, vasogenic

cerebral infarction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, culture of, viral

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrospinal fluid, red cells in

cerebrovascular accident

cerebrovascular accident, bilateral

cerebrovascular accident, familial occurrence

cerebrovascular accident, multiple

cerebrovascular accident, recurrent

cerebrovascular accident, women

cervical spine

chasing the dragon

chemotherapy, CNS treatment and complications with

children

chin numbness

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

cognition

collagen vascular disease

coma

complications

confusion

confusional state, acute

controversies in neurology

cop 1

corpus callosum

corpus callosum, lesion of

degenerative diseases of CNS

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dental procedure, neurologic complications with

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

dizziness

drug abuse

drug abuse, inhalation

drug abuse, neurologic complications of

drug induced neurologic disorders

electroencephalogram, abnormalities of

electromyogram

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

endocarditis

epidemiology of neurology

Epstein-Barr virus

Erdheim-Chester disease

ethics in neurology

evoked potentials

extinction on double simultaneous stimulation

eye movement, disorders of

face, numbness of

facial weakness

facial weakness, bilateral

falling

familial

food-borne infection

fourth ventricle, shift of

gadolinium

gait disorder

gammaglobulin therapy, intravenous

gastroenteritis

gaze palsy

gaze palsy, horizontal

gender

gene mutation

genetic neurologic disorders

gliomatosis cerebri

glutamic acid decarboxylase, antibody

granular osmiphilic material

granulomatous disease

headache, sudden onset of

headache, thunderclap

hearing loss

hearing loss, sudden, unilateral

heel-knee-shin test

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

herpes simplex virus

herpes virus

herpes zoster

herpes zoster, ophthalmicus

hiccoughs

histiocytosis

human immunodeficiency virus type 1

human immunodeficiency virus type 1, asymptomatic

hydrocephalus

hydrocephalus, exvacuo

hyperreflexia

hypersomnia

hypertensive encephalopathy

iatrogenic neurologic disorders

immunomodulation

immunosuppressive agents

incoordination

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intravenous

Jakob-Creutzfeldt disease

Kayser-Fleischer ring

laughing, pathologic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

leukoencephalopathy, toxic

level of consciousness, decreased

limbic encephalitis

listeria monocytogenes

lymphoma involving CNS

lymphoma, primary of CNS

MAGNIMS group

McDonald criteria for MS

medulla oblongata, lesion of

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis, aseptic

mental nerve

mental nerve neuropathy

mental status, abnormal

migraine

mimics

misdiagnosis

mitochondrial disease

MRI, angiography, false negative

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, incidental finding

MRI, snowball lesions

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, clinically isolated syndrome

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pain in

multiple sclerosis, paroxysmal symptoms in

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

N-acetyl-L-aspartic acid

nausea and vomiting

neoplasm, metastatic

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuroophthalmology

neuropathology

neuroprotective agents

Notch3 gene

numb chin syndrome

nystagmus

nystagmus, primary position of gaze

ocular bobbing

optic nerve, lesion of

optic neuritis

optic neuritis, etiology of

optic neuritis, treatment of

optical coherence tomography

optokinetic nystagmus(O.K.N.)

optokinetic nystagmus, abnormal

osteoblastic lesions, causes of

pain

pain, back

paraneoplastic cerebellar degeneration

Parkinsonism syndrome

paroxysmal neurologic deficits

PAS positive

PAS positive material in the brain

periventricular leukomalacia

personality change

phenylketonuria

pleocytosis of cerebrospinal fluid

pons, infarction of

pons, lesion of

posterior fossa

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudobulbar palsy

psychiatric problems in neurologic disorders

pursuit eye movements, abnormal

pyramidal tract

pyramidal tract dysfunction

quadriparesis

quadriplegia

race

radiation therapy, CNS treatment and complications with

Rankin score

rapidly progressing neurologic illness

Red flags

rehabilitation for neurologic disorders

remote effect of cancer on the nervous system

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis factor(R.A.factor)

rigidity

risk factors

saccadic eye movements, abnormal

scotoma, paracentral-homonymous

sedimentation rate, elevated

seizure

sensorineural hearing loss

serologic testing

sickle cell disease

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spinal cord, cervical

spinal cord, ischemic lesion of

spinal cord, lesion of

standing difficulty

steroid

steroid therapy, CNS treatment and complications with

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

Susac's syndrome

symmetric brain lesions

symptomatic

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tandem gait, ataxic

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thyroiditis

tinnitus

tongue, impaired movements of

tonic spasms

toxic encephalopathy

treatment of neurologic disorder

tremor

trigeminal neuralgia

trigeminal neuropathy

trigeminal neuropathy, sensory

vasculitides

vasculopathy

vasoconstrictive drugs

vasospasm, cerebral

ventricular enlargement

visual evoked response

visual field defect

visual symptoms

walking, difficulty with

water channel antibodies

white matter disease, periventricular

work loss

workup

Showing articles 800 to 850 of 4597 << Previous Next >>

MRI Characteristics of the MLF in MS Patients with Chronic Internuclear Ophthalmoparesis
Neurol 57:762-768, Frohman,E.M.,et al, 2001

The Prevalence of Sjogren Syndrome in Patients with Primary Progressive Multiple Sclerosis
Neurol 57:1359-1363,1357, de Seze,J.,et al, 2001

Oligoclonal Band Number as a Marker for Prognosis in Multiple Sclerosis
Arch Neurol 58:2044-2045, Avasarala,J.R.,et al, 2001

Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000

A 44-Year-Old Woman with Difficulty Walking
JAMA 284:2632-2639, Iezzoni,L.I., 2000

The Clinical Spectrum of Anti-GAD Antibody-Positive Patients with Stiff-Person Syndrome
Neurol 55:1531-1535, Dalakas,M.C.,et al, 2000

Conjugal Multiple Sclerosis: Population-Based Prevalence and Recurrence Risks in Offspring
Ann Neurol 48:927-931, Evers,G.C.,et al, 2000

Relative Contributions of Brain and Cervical Cord Pathology to Multiple Sclerosis Disability: a Study with Magnetisation Transfer Ratio Histogram Analysis
JNNP 69:723-727, Rovaris,M.,et al, 2000

Topiramate Relieves Refractory Trigeminal Neuralgia in MS Patients
Neurol 55:1587-1588, Zvartau-Hind,M.,et al, 2000

Diffusion-Weighted MR Imaging of the Brain
Radiology 217:331-345, Schaefer,P.W.,et al, 2000

Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000

Acute Aphasia in Multiple Sclerosis
Arch Neurol 57:1207-1209, Devere,T.R. et al, 2000

Health-Related Quality of Life in Neurology
Arch Neurol 57:1224-1227, Meyers,A.R. et al, 2000

Trauma to the Central Nervous System May Result in Formation or Enlargement of Multiple Sclerosis Plaques
Arch Neurol 57:1074-1076,1078, Poser,C.M., 2000

What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000

Cerebral Infarctin in the Term Newborn: Clinical Presentation and Long-Term Outcome
J Pediatr 137:351-355, Sreenan,C. et al, 2000

Psychological Stress and the Subsequent Appearance of New Brain MRI Lesions in MS
Neurol 55:55-61, Mohr,D.C. et al, 2000

Trauma Does Not Precipitate Multiple Sclerosis
Arch Neurol 57:1077-1078, Cook.S.D., 2000

Cerebrospinal Fluid Oligoclonal IgG Bands in Patients With Spinal Arteriovenous Malformation and Structural Central Nervous System Lesions
Arch Neurol 57:553-557, Cohen,O.,et al, 2000

Poliomyelitic-Like Illness in Central European Encephalitis
Neurol 55:299-302, Schellinger,P.D. et al, 2000

Optic Neuritis in Multiple Sclerosis: An Update
The Neurologist 6:205-213, Chan,J.W., 2000

Disability in Young People and Adults One Year after Head Injury: Prospective Cohort Study
BMJ 320:1631-1635, Thornhill,S. et al, 2000

De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000

Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000

Effect of Interferon B-1b in MS, Assessment of Annual Accumulation of PD/T2 Activity on MRI
Neurol 54:200-206, Zhao,G.J.,et al, 2000

A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000

Total Brain N-Acetylaspartate, A New Measure of Disease Load in MS
Neurol 54:15-19, Gonen,O.,et al, 2000

Amyotrophic lateral Sclerosis Mimic Syndromes, A Population-Based Study
Arch Neurol 57:109-113, Traynor,B.J.,et al, 2000

Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000

Pathologic Damage in MS Assessed by Diffusion-Weighted and Magnetization Transfer MRI
Neurol 54:1139-1144, Cercignani,M.,et al, 2000

Progressive Cerebral Atrophy in MS
Neurol 54:807-812,782, Fox,N.C.,et al, 2000

Glossopharyngeal Neuralgia and MS
Neurol 54:1368-1370, Minagar,S.&Sheremata,W.A., 2000

Primary Neurosarcoidosis:A Diagnostic and Therapeutic Challenge
The Neurologist 6:126-133, Nikhar,N.K.,et al, 2000

Outcome of Surgery for Thoracic Outlet Syndrome in Washington State Workers' Compensation
Neurol 54:1252-1257, Franklin,G.M.,et al, 2000

Multiple Sclerosis and Antecedent Infections
Neurol 54:2307-2310, Marrie,R.A.,et al, 2000

Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000

Heterogeneity ofMultiple Sclerosis Lesions: Implications for the Pathogenesis of Demyelination
Ann Neurol 47:707-717, Lucchinetti,C.,et al, 2000

Open-Ring Imaging Sign
Neurol 54:1427-1433, Masdeu,J.C.,et al, 2000

Practice Parameter: The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients With Suspected Multiple Sclerosis (an Evidence-Based Review)
Neurol 54:1720-1725, Gronseth,G.S.&Ashman,E.J., 2000

Neurologic and Developmental Disability After Extremely Preterm Birth
NEJM 343:378-384,429, Wood,N.S. et al, 2000

Functional Outcomes After Gamma Knife Thalamotomy for Essential Tremor and MS-Related Tremor
Neurol 55:443-446, Niranjan,A. et al, 2000

Reduced Signal Intensity of T2 Weighted MR Imaging of Thalamus and Putamen in Multiple Sclerosis in Japan
Rinsho Shinkeigaku 40:677-682, Nishii,T.,et al, 2000

Familial Neuromyelitis Optica (Devics Syndrome) with Late Onset in Japan
Neurol 55:318-320, Yamakawa,K.,et al, 2000

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
Ann Int Med 131:919-926, Shadick,N.A.,et al, 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999

Showing articles 800 to 850 of 4597 << Previous Next >>